Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03356860Phase 1/2Completed
Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Breast CancerLuminal BTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2017-04-13

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cliniques universitaires Saint-Luc (UCL)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Javier Carrasco, MD, PhD

GHdC

Moderately Similar
2 trials

Shared therapeutic areas:

Breast CancerLuminal BTriple Negative Breast Neoplasms

Worked with same sponsors:

Cliniques universitaires Saint-Luc- Université Catholique de LouvainGrand Hôpital de Charleroi
Collaborated on 1 trial
Similarity Score34%

Jean-Luc Canon, MD

GHdC

Moderately Similar
1 trials

Shared therapeutic areas:

Breast CancerLuminal BTriple Negative Breast Neoplasms

Worked with same sponsors:

Cliniques universitaires Saint-Luc- Université Catholique de LouvainGrand Hôpital de Charleroi
Collaborated on 1 trial
Similarity Score34%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerTriple Negative Breast Neoplasms
Similarity Score20%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast CancerTriple Negative Breast Neoplasms
Similarity Score20%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03356860Phase 1/2PrincipalInvestigator

Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.

Breast CancerLuminal BTriple Negative Breast Cancer
Completed

All 1 trials loaded